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ABSTRACT MAX 150 WORDS (150 HERE) 
Very little is known about the natural history of oral HPV infection. Several different methods exist 
to collect oral specimens and detect HPV, but their respective performance characteristics are 
unknown. We compared two different methods for oral specimen collection (oral saline rinse and 
commercial saliva kit) from 96 individuals and then analyzed the samples for HPV by two different 
PCR detection methods (single GP5+/6+ PCR and nested MY09/11 and GP5+/6+ PCR). For the oral 
rinse samples, the oral HPV prevalence was 10.4% (GP+ PCR; 10% repeatability) vs 11.5% (nested 
PCR method; 100% repeatability). For the commercial saliva kit samples, the prevalences were 3.1% 
vs 16.7% with the GP+ PCR vs the nested PCR method (repeatability 100% for both detection 
methods). Overall the agreement was fair or poor between samples and methods (Kappa 0.06-0.36). 
Standardizing methods of oral sample collection and HPV detection would ensure comparability 
between future oral HPV studies. 
 
 
Key words: oral HPV infection; oral specimen collection method; HPV detection method, saliva 
sample; oral rinse sample 
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1. INTRODUCTION 
To date 205 different human papillomavirus (HPV) types that can infect skin or mucosa have been 
fully characterised (Bernard, et al., 2010; de Villiers, 2013)(http://pave.niaid.nih.gov).  It is well 
established that high-risk HPV types from the alpha-genus infecting the mucosal epithelia are the 
causative agents of cervical cancer and other (ano)genital cancers (Walboomers, et al., 1999; zur 
Hausen, 2002). In the last decades, these mucosal high-risk HPV types have been detected in 
increasing prevalence in mucosal head and neck squamous cell carcinomas (HNSCCs), particularly in 
cancers of the oropharynx (A. Hong, et al., 2014; A. M. Hong, et al., 2010; Nasman, et al., 2009).  
While most aspects of the natural history of HPV infections of the human cervix are well-studied, the 
natural history of HPV infection in the oral cavity and pharynx of ‘healthy’ humans (i.e. people 
without cancer) is barely understood. Further, almost nothing is known about the molecular 
pathways through which HPV infection of the oral and pharyngeal mucosa contributes to HNSCC. 
While extrapolations on causal mechanisms might be made from observations of cervical 
carcinogenesis, the analogy is not perfect and sufficient differences exist to warrant caution in such 
an approach. 
Studies of the natural history of HPV infection of the oral cavity and pharynx require samples to be 
collected from ‘free-living’ human volunteers. There are several methods to collect oral specimens, 
and there are also several PCR-based methods that detect oral HPV infection, which are used in 
epidemiological and clinical studies to diagnose mucosal HPV infection (Clifford, et al., 2016; de Roda 
Husman, Walboomers, van den Brule, Meijer, & Snijders, 1995; Manos, et al., 1989). The most 
commonly used method to collect specimens to date has been oral rinse, followed by a single PCR 
test to detect HPV (Wood, Bain, Smith, Whiteman, & Antonsson, 2017).  However, it is suspected 
(though not proven) that these various sample methods and techniques differ in performance, in 
sensitivity and HPV type specificity.  Here we have compared the performance of two different 
methods for collecting oral specimens, and also compared the performance of two different PCR 
methods for detecting HPV. 
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2. MATERIALS AND METHODS 
2.1 Study population and questionnaire data 
We recruited 96 individuals who were attending general practitioner clinics in Brisbane, Australia. 
Written informed consent was obtained from all patients. This study was approved by the Human 
Research Ethics Committee of QIMR Berghofer Medical Research Institute (P2048).  
Participants were asked to self-complete a paper-based 4-page questionnaire.  The questionnaire 
covered: 1). Demographic details: age, sex, post code, place of birth, education etc. 2). Life-style 
factors: exercise, alcohol consumption, smoking and illicit drug use. 3). Medical history for HPV-
related disease and other sexually transmitted disease: past history, treatment and diagnosis for 
HPV-related disease, including Pap smear history of self and/or partner. 4). Prevention of HPV-
related disease: if received the HPV vaccine Gardasil®, age at first vaccination and number of doses 
received. 5). Sexual behaviour and orientation: Questions about passionate (“open-mouthed’) 
kissing, oral sex, sexual intercourse and sexual gender preference. 
We did not do a physical examination of the oral cavity of the participants of our study. Instead, we 
asked participants how often they saw a dentist. 
2.2 Oral specimens and DNA extraction  
We collected two different oral specimens from each participant, one oral saline rinse sample and 
one commercial saliva kit sample. The oral saline rinse sample was collected first followed by the 
commercial saliva collection kit within one minute. 
Oral saline sample. Participants rinsed their mouth with 7 ml sterile saline (0.9%) for 30 seconds. All 
oral rinse specimens were kept on ice after collection and were then transferred to a frost-free 
freezer at -20˚C within 3 hours of collection. The oral saline samples were kept at -20°C between 6 
months to 2 years and 3 months before being analysed. Specimens were thawed at ambient room 
temperature for approximately 15 mins, vortexed, and 200 µl was used for DNA extraction. 
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Commercial saliva kit sample. Saliva specimens were collected with Omnigene Discover kits for 
collection of microbial DNA (OM-501; DNA Genotek Inc, Ottawa, ON, Canada), which are specifically 
developed for the collection and stabilisation of microbial DNA from saliva. For DNA extraction, 200 
µl was aliquoted to a new tube, heat inactivated at 50˚C for 2 hour, followed by 15 min at 75˚C. 
We used 200 µl of either oral saline sample and or commercial saliva kit sample to extract DNA with 
the Promega Maxwell® viral kit (Maxwell® 16 Viral Total Nucleic Acid Purification Kit, Promega, 
Madison, WI, USA) as per the manufacturer’s instructions for DNA extraction. Polymerase chain 
reaction (PCR) tests 
2.2.1 HPV DNA testing 
The extracted DNA samples were analysed by PCR for the presence of HPV with two different PCR 
tests: 1). nested PCR using outer primers MY09/MY11 (GeneWorks Pty Ltd, Adelaide, SA, Australia)  
(Manos, et al., 1989) and the inner primers GP5+/GP6+ (GeneWorks) (de Roda Husman, 
Walboomers, van den Brule, et al., 1995) and 2). the general mucosal HPV primer GP5+/GP6+ (de 
Roda Husman, Walboomers, van den Brule, et al., 1995) in a single standard PCR reaction.  
The final volume of PCR solution (25 μl) contained 5 µl of extracted sample DNA, 0.5 μM of each 
forward primer (MY09 or GP5+) and each reverse primer (MY11 or GP6+), dNTPs at concentrations 
of 0.2 mM each (Fisher Biotec, Wembley, WA, Australia), 1 U of AmpliTaq Gold DNA polymerase, 1x 
PCR Gold buffer and 2.0 mM MgCl2 (Applied Biosystems, Foster City, CA, USA). Forty cycles of 
amplification was performed on a Bio-Rad S1000™ Thermal Cycler (Gladesville, NSW, Australia) after 
an initial step of 10 minutes denaturation at 94°C. Each cycle for the GP+ PCR consisted of 94°C for 1 
min, 40°C for 2 min and 72°C for 1.5 min, plus a final elongation step at 72°C for 4 min. The cycle for 
the MY PCR was the same as for the GP+ PCR, with the exception that the annealing temperature 
was 48°C.  
To minimize the risk for contamination we used different pipettes and rooms for DNA extraction, 
preparing the PCR solution, adding DNA samples to PCR solution and electrophoresis analysis.  
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In each batch of tests, HeLa cells (HPV-18 positive cervical cell line) were used as a positive control. 
H2O was used as a negative control, and a negative control was included after seven samples (every 
eighth tube). PCR amplicons were analysed by electrophoresis (1.5% agarose gel containing ethidium 
bromide; SeaKem, FMC bioproducts and Sigma) and identified under UV light.  
We conducted the single PCR reaction with GP+ 3 times on each sample, and we conducted nested 
PCR twice for each sample. Samples were considered positive if they tested positive at least once in 
the PCR runs. 
2.2.2 Beta-globin PCR 
β-globin PCR with the primers PCO3 and PCO4 (GeneWorks) (de Roda Husman, Walboomers, 
Hopman, et al., 1995) was carried out on all samples to ensure that no PCR inhibiting agents were 
present and that they contained human DNA. The same conditions and concentrations of PCR 
reagents were used, with the exception of an annealing temperature of 50°C. In each batch of 
tests, human genomic DNA: Male (Promega) was used as a positive control , while H2O 
was used as a negative control.  
2.4 HPV Type Determination 
The HPV-positive PCR products were purified directly from the PCR reaction with the Agencourt® 
AMPure PCR purification kit (Bioscience Beckman Coulter, Beverly, MA, USA) in a magnetic 96-ring 
SPRIplate®. The sequencing reaction (total volume of 15 µl) contained the purified PCR products (8 
µl) together with 3.25 μM of primer (GP5+ or GP6+) and BigDye Terminator (0.5 µl; version 3.1, 
Applied Biosystems) and BigDye sequencing buffer (3 µl; Applied Biosystems) and sterile water. The 
sequencing reaction was performed in a Bio-Rad S1000™ Thermal Cycler. After an initial step of 96°C 
for 2 min, 30 cycles followed, each with 96°C for 10 s, 50°C for 5 s and 60°C for 2 minutes. The 
sequence reactions were purified with the Agencourt® CleanSEQ dye-terminator removal kit 
(Beckman Coulter) in a magnetic 96-ring SPRIplate®, and 10 µl purified sequence reactions were 
analysed with an automated DNA sequencer (Applied Biosystems ABI PRISM ® 3100 Genetic 
Analyser). The DNA sequences obtained were compared with available sequences in GenBank 
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through the BLAST server (http://blast.ncbi.nlm.nih.gov). Sequencing was repeated up to four times, 
and was deemed HPV-positive, but not HPV typed if no DNA sequence was obtained from 
sequencing. 
2.5 Statistical Analysis 
Four 2x2 cross-classification tables were used to assess agreement of HPV detection of saline rinse 
vs commercial saliva collection kit samples with the Nested PCR, as well as with the GP primer DNA 
test, and to compare the Nested DNA testing method versus the GP primer DNA test with the saline 
rinse collection method and with the commercial saliva kit collection method.   
For each comparison a Kappa Coefficient was calculated with 95% confidence intervals to assess 
agreement (Fleiss, J., & Everitt, 1969), and a McNemar’s test to assess symmetry of agreement.    
3. RESULTS 
3.1 Participants 
Fifty-one percent of participants were females and 49% were in the youngest age category (20-29 
years). Demographic and clinical characteristics of the 96 participants studied are presented in Table 
1.  
3.2 DNA quality of samples 
All samples (saline rinse and commercial saliva samples) tested positive for beta-globin by 
PCR (the PCR DNA quality control test), which indicates convincingly that there was 
sufficient cellular material to perform the PCR assays and that the samples did not contain 
any PCR inhibiting material. Comparing the DNA concentration from the two samples 
donated by the same person, we found that in 86 of the 96 sample pairs the DNA 
concentration was higher in the commercial saliva collection kit. 
3.3 HPV prevalence and concordance between sample method and HPV PCR method 
The measured prevalence of HPV in oral samples varied markedly, depending on the collection 
method and the detection method. Thus, for oral rinse samples collected in saline, we observed an 
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oral HPV prevalence of 10.4% (10/96) vs 11.5% (11/96) using the GP+ PCR vs nested PCR methods, 
respectively. For saliva samples collected using commercial kits, we observed prevalences of 3.1% 
(3/96) vs 16.7% (16/96) using the GP+ PCR vs the nested PCR method (Table 2).  
The agreement between the saline and commercial saliva samples from the same individual was 
better when analysed with the same HPV detection method (Kappa 0.36 and 0.11) than when 
different PCR detection methods were used for the same sample (saline rinse or commercial saliva 
kit; Kappa 0.09 and 0.06; Table 3). Overall the agreement was fair or poor between samples and 
methods. 
3.4 Concordance of findings from different collection methods and different HPV 
detection methods. 
For HPV analysis of the commercial saliva collection kit samples the repeatability was 100%, the 3 
HPV-positive samples tested positive and the 93 HPV-negative samples tested negative in all 3 GP+ 
PCR runs. The repeatability was also 100% for the commercial saliva collection kit samples when 
tested with the nested PCR; all 16 samples tested positive for HPV and all 80 samples tested negative 
for HPV in both nested PCR runs. 
For the saline rinse samples tested by GP+ PCR, 10 tested positive at least once, with one rinse 
sample being GP+ positive in all three PCR runs; three samples positive in two of the runs and six 
positive in one of PCR runs). The repeatability for saline rinse samples tested with nested PCR was 
100% (all eleven HPV-samples tested positive and all 85 HPV-negative samples tested negative in 
both nested PCR runs). 
3.5 HPV types 
Overall from the paired sets of samples collected using two different methods, 16 different HPV 
types were isolated with HPV-16 being the most commonly identified.. HPV types detected in 13 
saliva or saline samples testing HPV-positive with GP+ PCR were: HPV-16, -18, -31, -32, -33, and -35. 
We were unable to type six of the samples which tested positive with GP+. With the nested PCR, we 
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found 27 HPV-positive samples and the following HPV types: HPV-2, -11, -12, -16, -32, -33, -35, -45, -
53, -59, -62, -73, -81, and -124 (plus two samples that could not be HPV typed). 
There was no concordance between HPV types in the commercial saliva kit sample using GP+ and 
nested PCR. Only one HPV type (HPV-32) was found with both detection methods in a saline sample. 
There was no concordance between HPV types in the two different samples from each individual 
using the GP+ method, but we found HPV-31 in the saliva sample collected with a commercial kit 
and could not HPV type the corresponding HPV-positive saline sample. Using the nested PCR, the 
same HPV type was isolated in the same individuals, but in different samples from three people 
(HPV-16, -53 and -59). 
 
4. DISCUSSION 
The objective of the present study was to compare two methods for collecting samples of oral 
mucosal cells, and to compare two methods for detecting HPV DNA in those cells based on PCR, with 
a view to optimizing protocols for future investigations into the natural history of oral HPV infection.  
We found that observed oral HPV prevalence varied significantly between the saline rinse method 
and the commercial saliva collection kit as well as between the two HPV detection methods, all with 
fair to poor concordance when compared. The HPV types detected in commercial saliva kit and 
saline rinse samples from the same individual had concordance that was very poor, with only a 
handful of HPV positive samples harbouring the same HPV type. 
Several recent studies have used sampling techniques such as surface brushings to detect HPV DNA 
in tumour samples (Kofler, et al., 2017) or leucoplakia (Dalla Torre, et al., 2015), but those studies 
did not directly compare the performance of different sampling techniques against each other. 
There are advantages and disadvantages with both sample collection methods. The commercial 
saliva sample kits are easy to use, contain a preservative liquid and can therefore be mailed out and 
mailed back (sample stable for 12 months at room temperature), but are quite expensive. On the 
other hand, oral saline rinse samples have been the most commonly used method for specimen 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
10 
 
collection for oral HPV prevalence studies (Wood, et al., 2017). The oral saline rinse method is cheap, 
although those samples need to be put on ice and kept in a freezer as saliva contains enzymes that 
break down RNA and DNA if not frozen within reasonable time. In the present study, saline rinse 
samples were placed on ice immediately after collection and then transferred to a freezer within 3 
hours. For follow-up in longitudinal field studies, commercial saliva collection kits are more 
appealing for the convenience of being able to collect samples remotely, through postal or courier 
services.  
A recent publication (Clifford, et al., 2016), compared the performance of the commonly used HPV 
detection and typing methods GP5+/6+ PCR followed by reverse dot blot hybridization (GP5+/6+ 
RLB) and multiplex type-specific E7-based bead-based multiplex HPV genotyping (MPG) assay (E7-
MPG) on almost 5,000 cervical cell and urine samples. Both methods detected 22% HPV positive 
samples, 14% were positive with the E7-MPG method only and 0.5% positive with the GP5+/6+ RLB 
method only.  
In addition to the method of collecting oral samples and the method for detecting HPV, the method 
of extracting DNA seems to also influence findings. D’Souza et al (2005) compared five different 
methods of DNA extraction of Scope mouthwash sample from 20 individuals. They found significant 
differences between DNA extraction methods. DNA extraction affected not only DNA-quality 
(measured with β-globin PCR, range 50-100% positive), but also the ability to determine HPV status 
(range 11%-65%) as well as the number of HPV types detected (range 2-13 HPV types) (D'Souza, 
Sugar, Ruby, Gravitt, & Gillison, 2005).  Method of DNA extraction is also something to consider 
when looking for the gold standard method for studies of the natural history of oral HPV in 
populations. 
The nested MY09/11 and GP5+/6+ PCR has been reported to be more type sensitive, detecting a 
wider range of HPV types, low copy number HPV infections and more infections with multiple HPV 
types than MY09/11 PCR or GP5+/6+ PCR alone (Fuessel Haws, et al., 2004). Nested PCR is more 
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time consuming compared to a single PCR reaction, and single MY09/11 PCR has so far been the 
most commonly used method of detection for HPV in oral samples (Wood, et al., 2017).  
We found that all commercial saliva kit and saline rinse samples, tested with the nested PCR were 
internally repeatable (100%) in both PCR tests. Likewise, GP+ PCR was also 100% internally 
repeatable for the commercial saliva kit collection method. However, when using the GP+ PCR 
method on the saline rinse samples, we found that only one out of ten positive samples tested 
positive in all three PCR runs (while nine tested positive once or twice in the three runs). We do not 
believe this is an operator error as the same highly experienced person conducted all laboratory 
work and the repeatability was 100% for the other three combinations of sample/detection method. 
The reason for this low repeatability of saline rinse in combination with GP+ PCR could be because 
saline rinse samples might have fewer viral copies than the commercial saliva kit. This might 
eventuate due to degradation by saliva enzymes, even in a short space of time. In addition, it is 
possible that the rinse method collects fewer cells than the commercial saliva collection kit. The 
problems of ‘HPV under-detection’ by the oral rinse method outlined above would likely be 
compounded by the lower sensitivity of GP5+/6+ PCR method when compared with nested PCR 
(Fuessel Haws, et al., 2004). Furthermore, it is possible that the sequence order of sample collection 
could be a factor that might explain the findings. Taken together, the viral copy number in the oral 
rinse samples might simply be too low to be detected reliably. One limitation of this study is that we 
were unable to HPV type eight samples (saline rinse and commercial saliva kits) that were positive 
with the single PCR test GP+. The reasons for this could be either that the samples contained more 
than one HPV type (we used direct sequencing of PCR products, which means only one HPV type can 
be detected) or it could also mean that those samples were false positives.  
Overall, we found that the commercial saliva collection kit and the nested PCR method had the 
highest repeatability for detecting HPV. This combination of commercial saliva collection kit and 
nested PCR was also the collection/detection method combination yielding the highest oral HPV 
prevalence.  Assuming these findings are replicated in other settings, we contend that saliva samples 
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collected in robust kits, coupled with analysis using nested PCR, offers the most reliable approach for 
field studies that aim to determine the presence of HPV in samples collected from the oropharynx.  
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Table 1 Participant characteristics (n=96) 
 
Characteristic  N (%)* 
Gender   
 Female  49 (51.0) 
 Male 47 (49.0) 
Age   
 20-29 47 (49.0) 
 30-39 24 (25.0) 
 40-49 11 (11.5) 
 50-59 8 (8.3) 
 60-70 6 (6.2) 
BMI  
 Healthy (18.5-24.9) 53 (55.2) 
 Overweight (25-29.9) 26 (27.1) 
 Obese (30.0 or more) 14 (14.6) 
 Missing 3 (3.1) 
Marital Status  
 Single/ Never married 53 (55.2) 
 Married/ de facto/living with partner 37 (38.6) 
 Divorced/ Separated 3 (3.1) 
 Widowed 0 
 Missing 3 (3.1) 
Education  
 School only 13 (13.5) 
 Tech/Diploma 14 (14.6) 
 University 62 (64.6) 
 Missing 7 (7.3) 
Australian Born  
 No 42 (43.7) 
 Yes 50 (52.1) 
 Missing 4 (4.2) 
Smoker   
 Never 64 (66.7) 
 Former  15 (15.6) 
 Current  14 (14.6) 
 Missing 3 (3.1) 
Illicit drug use in the last 12 months 
 Never 65 (67.8) 
 Once or twice 20 (20.8) 
 Monthly or more often 8 (8.3) 
 Missing 3 (3.1) 
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Given oral sex in a lifetime 
 no 8 (8.3) 
 yes 83 (86.5) 
 Missing 5 (5.2) 
Ever received  oral sex in a lifetime 
 no 10 (10.4) 
 yes 81 (84.4) 
 Missing 5 (5.2) 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
18 
 
Table 2  Oral HPV positive results from 96 individuals for saline rinse and commercial saliva collection 
kit samples using GP+ PCR and nested PCR; n(%). 
  
   Saline rinse Commercial saliva collection kit 
GP+ PCR 10 (10.4%) 3 (3.1%) 
Nested PCR 11 (11.5%) 16 (16.7%) 
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Table 3 Comparison and concordance between sample method and PCR method 
 
 N=96 Both positive (n) Both negative (n) Pos vs Neg (n) Neg vs Pos (n) Overall agreement 
n (%) 
Kappa 
value 
95% CI for 
Kappa 
sample Saline rinse vs commercial saliva collection 
kit with GP+ method 
1 84 9 2 85 (88%) 0.11 -0.15-0.37 
sample Saline rinse vs commercial saliva collection 
kit with nested method 
6 75 5 10 81 (84%) 0.36 0.10-0.61 
PCR GP+ vs nested with saline rinse samples 2 77 8 2 79 (82%) 0.09 -0.15-.33 
PCR GP+ vs nested with commercial saliva 
collection kit samples 
1 78 15 2 79 (82%) 0.06 -0.13-0.24 
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 There are several different methods for specimen collection and oral HPV detection 
 We compared two different methods for oral specimen collection 
 Samples were tested for HPV by two different PCR detection methods 
 Oral HPV prevalence ranged from 3% to 17% depending on combination of methods 
 There is a need to standardise methods of oral sample collection and HPV detection 
